Rabei Obayda, Al-Rasheed Ula, Alrammahi Mohammed, Al-Ibraheem Akram
Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), 202 Queen Rania St., P.O. Box 1269, Amman, Jordan.
World J Nucl Med. 2023 Dec 26;22(4):306-309. doi: 10.1055/s-0043-1777694. eCollection 2023 Dec.
Sarcoidosis is frequently associated with various hematological and solid tumors; it can be discovered by chance during tumor evaluations. Sarcoidosis can occur before some cancers, coexist with others, or be diagnosed 1 to 2 years later. Sarcoid reaction affecting hilar and mediastinal lymph nodes can pose a diagnostic challenge in patients with histopathological confirmation of Hodgkin lymphoma who are being evaluated using fluorodeoxyglucose-positron emission tomography computed tomography (FDG-PET/CT) scan because it cannot be easily distinguished from lymphoma infiltration. The presence of an increase or persistence of a prominent activity on a follow-up FDG-PET/CT scan after chemotherapy treatment for lymphoma that is associated with a complete metabolic response in the site of the primarily diagnosed lymphomatous disease is highly suggestive of concurrent sarcoidosis and necessitates careful assessment to avoid unnecessary therapy.
结节病常与各种血液系统肿瘤和实体瘤相关;它可能在肿瘤评估期间偶然被发现。结节病可在某些癌症之前出现,与其他癌症共存,或在1至2年后被诊断出来。对于经组织病理学证实为霍奇金淋巴瘤且正在接受氟脱氧葡萄糖正电子发射断层扫描计算机断层扫描(FDG-PET/CT)检查的患者,影响肺门和纵隔淋巴结的结节病反应可能会带来诊断挑战,因为它不易与淋巴瘤浸润区分开来。淋巴瘤化疗后,在最初诊断的淋巴瘤疾病部位出现完全代谢反应的情况下,随访FDG-PET/CT扫描显示显著活性增加或持续存在,高度提示并发结节病,需要仔细评估以避免不必要的治疗。